| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.21 | 2e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-06 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.24 | 7e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.2 | 2e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.2 | 3e-05 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |